loading page

Successful treatment of interstitial pneumonia with autoimmune features using rituximab as salvage therapy
  • Abeline Kapuczinski,
  • Michel Cotils,
  • Yannick Gombeir
Abeline Kapuczinski
Hospital Centre EpiCURA Hornu
Author Profile
Michel Cotils
Hospital Centre EpiCURA Hornu
Author Profile
Yannick Gombeir
Hospital Centre EpiCURA Hornu
Author Profile

Abstract

Interstitial pneumonia with autoimmune features is a concept to identify patients with idiopathic interstitial pneumonia and features suggestive of a connective tissue disease. There is no specific treatment which consists mainly of corticosteroids and immunossupressive agents. Rituximab is an effective rescue therapy for refractory interstitial lung disease.

Peer review status:ACCEPTED

19 Feb 2021Submitted to Clinical Case Reports
20 Feb 2021Submission Checks Completed
20 Feb 2021Assigned to Editor
27 Feb 2021Reviewer(s) Assigned
04 Mar 2021Review(s) Completed, Editorial Evaluation Pending
08 Mar 2021Editorial Decision: Revise Minor
02 Apr 20211st Revision Received
03 Apr 2021Submission Checks Completed
03 Apr 2021Assigned to Editor
03 Apr 2021Review(s) Completed, Editorial Evaluation Pending
07 Apr 2021Editorial Decision: Accept